| Health / Medical Topics |
Tremelimumab
Pronunciation
Definition 1
A substance being studied in the treatment of some types of cancer. Tremelimumab binds to a protein called CTLA-4, which is found on the surface of T cells (a type of white blood cell). It may block CTLA-4 and help the immune system kill cancer cells. Tremelimumab is a type of monoclonal antibody and a type of immunomodulatory agent. (NCI Dictionary)
Definition 2
A human IgG2 monoclonal antibody directed against the T-cell receptor protein cytotoxic T-lymphocyte-associated protein 4 (CTLA4). Tremelimumab binds to CTLA4 and blocks the binding of the antigen-presenting cell ligands B7-1 and B7-2 to CTLA4, resulting in inhibition of B7-CTLA4-mediated downregulation of T-cell activation; subsequently, B7-1 or B7-2 may interact with another T-cell surface receptor protein, CD28, resulting in a B7-CD28-mediated T-cell activation unopposed by B7-CTLA4-mediated inhibition. (NCI Thesaurus)
Definition 3
A monoclonal antibody being studied in the treatment of melanoma and some other types of cancer. Ticilimumab is made in the laboratory and binds to a protein called CTLA-4 on T cells (a type of white blood cell). CTLA-4 is involved in preventing the activation of T-cells. Ticilimumab may block CTLA-4 and help the immune system kill cancer cells. It is a type of immunomodulatory agent. (NCI Dictionary)
YOU MAY ALSO LIKE
